Source: Walter and Eliza Hall Institute Summary: Researchers are homing in on a new target for malaria treatment, after developing a compound that blocks the action of a key 'gatekeeper' enzyme essential for malaria parasite survival. The compound, called WEHI-916, is the first step toward a new class of antimalarial drugs that could cure and prevent malaria infections caused by all species of the parasite, including those resistant to existing drugs
Wednesday, July 2, 2014
New compound that could work for malaria
Science daily
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment